We use cookies to ensure the website works properly and to improve your experience. By continuing to use the website, you agree to their use.
Для размещения заказа оставьте ваш номер телефона. Мы с вами свяжемся в ближайшее время
Рассчитать стоимость заказа
Оставьте свои контакты и мы свяжемся с вами в ближайшее время
RAPID HCV-Ab ELISA
Registration Certificate: № RZN 2024/24911
ELISA test kit for Qualitative detection of IgG and IgM antibodies to Hepatitis C virus in human serum or plasma
The Current Diagnostic Landscape
Viral hepatitis C is a global medical and social challenge: according to WHO data, there are approximately 50 million patients with chronic infection worldwide, with annual mortality reaching 242,000 cases.
The key difficulty in combating the disease lies in its low detection rate, as a prolonged asymptomatic course often leads to late diagnosis only at the stage of significant liver damage.
The key difficulty in combating the disease lies in its low detection rate, as a prolonged asymptomatic course often leads to late diagnosis only at the stage of significant liver damage.
Clinical Impact & Benefits
01
DISEASE DETECTION
The detection of antibodies to the virus using the ELISA method is an essential diagnostic standard and serves as a key criterion for confirming HCV infection.
02
MONITORING HIGH-RISK GROUPS
In accordance with the recommendations of the Ministry of Health of the Russian Federation and the WHO, a priority area is the mandatory screening of vulnerable populations, including blood donors and pregnant women.
Key Advantages
Qualitative detection
Extended shelf life reduces the risk of disposal and simplifies procurement planning
Technical Specifications
Total Incubation Time:
80 minutes
Coefficient of Variation (CV):
8%
Compatibility:
Fully compatible with ELISA analyzers
Shelf life:
24 months
Submit a request to receive a commercial offer
We will contact you shortly
Related Products
